Pharmacogenetics of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) in cardiovascular diseases
L da Cunha Agostini, NNT Silva… - European Journal of …, 2024 - Elsevier
Cardiovascular diseases (CVDs) have a high mortality rate, and despite the several
available therapeutic targets, non-response to antihypertensives remains a common …
available therapeutic targets, non-response to antihypertensives remains a common …
Present and future of drug therapy in hypertension: an overview
J Redon, R Carmena - Blood Pressure, 2024 - Taylor & Francis
Purpose: High blood pressure (HBP) is the leading cause of mortality and years of disability,
and its prevalence is increasing. Therefore, diagnosis and effective treatment of HBP is one …
and its prevalence is increasing. Therefore, diagnosis and effective treatment of HBP is one …
[HTML][HTML] CYP11B1 gene polymorphisms and susceptibility to ischemic stroke in a Chinese Han population
G Liu, Y Duan - Frontiers in Neuroscience, 2022 - frontiersin.org
Objectives Ischemic stroke (IS) is the major cause of death and disability. While previous
studies confirmed that CYP11B1 is closely associated with IS, the present study aimed to …
studies confirmed that CYP11B1 is closely associated with IS, the present study aimed to …
[HTML][HTML] Management of Hypertension in the Asia-Pacific Region: A Structured Review
ARA Rahman, JDA Magno, J Cai, M Han… - American Journal of …, 2024 - Springer
This article reviews available evidence regarding hypertension management in the Asia-
Pacific region, focussing on five research questions that deal with specific aspects: blood …
Pacific region, focussing on five research questions that deal with specific aspects: blood …
[PDF][PDF] A network pharmacology-based analysis of Curcuma longa L.
Y Zhang, R Chen, W Xu - Int. J. Clin. Exp. Med., 2021 - e-century.us
Objective: To further analyze the pharmacological mechanism of Curcuma longa L. using
network pharmacology. Methods: In this study, superior compounds were identified through …
network pharmacology. Methods: In this study, superior compounds were identified through …
[PDF][PDF] Покращання діагностики і прогнозування тяжкості перебігу артеріальної гіпертензії з урахуванням модифікованих та немодифікованих предикторів
ЮВ Репчук - 2022 - nauka.bsmu.edu.ua
Untitled Page 1 Page 2 2 АНОТАЦІЯ Репчук ЮВ«Покращання діагностики і прогнозування
тяжкості перебігу артеріальної гіпертензії з урахуванням модифікованих та …
тяжкості перебігу артеріальної гіпертензії з урахуванням модифікованих та …
[PDF][PDF] The impact of angiotensin II type 1 receptor (ATR1) gene polymorphism (A1166C) on cardiovascular and renal complications in Iraqi hypertensive patients …
ZH Jasim, S Jubair, HAAN Abood - researchgate.net
Angiotensin II is the most vasoactive peptide and a powerful blood vessels constrictor of
renin-angiotensin-aldosterone system (RAAS). It affects arterial musculature, increases …
renin-angiotensin-aldosterone system (RAAS). It affects arterial musculature, increases …